Related Experiment Video
Updated: Jun 18, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Bioactive poly(amino acid)s for multi-modal cancer therapy
Guanqing Yang1, Jianxun Ding1,2, Xuesi Chen1,2
1Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China.
Developing novel bioactive poly(amino acid)s offers a promising strategy to overcome limitations in current cancer therapies by targeting tumor microenvironments (TMEs). These advanced materials modulate TMEs for enhanced multi-modal tumor treatment.
Area of Science:
- Oncology
- Nanomedicine
- Materials Science
Background:
- Tumor microenvironments (TMEs) significantly influence cancer progression and treatment efficacy.
- Current therapies often lack specificity for TMEs, necessitating advanced strategies.
- Bioactive materials, particularly poly(amino acid)s, show potential for TME modulation.
Purpose of the Study:
- To review recent advancements in developing bioactive poly(amino acid)s for multi-modal tumor therapy.
- To highlight the synthesis, properties, and TME-modulating capabilities of these materials.
- To explore structure-activity relationships and mechanisms for enhanced cancer treatment.
Main Methods:
- Overview of poly(amino acid) synthesis and their use as nanocarriers.
- Synthesis of biologically responsive, dynamically allosteric, and immunologically effective poly(amino acid)s.
- Investigation of poly(amino acid)s for modulating intracellular, extracellular matrix, and stromal cell microenvironments.
Main Results:
- Poly(amino acid)s demonstrate tunable properties for targeted TME modulation.
- Developed poly(amino acid)s exhibit responsiveness, allosteric regulation, and immune-modulating effects.
- These materials enhance tumor therapy by targeting various aspects of the TME.
Conclusions:
- Bioactive poly(amino acid)s represent a promising platform for innovative cancer therapy.
- Elucidating structure-activity relationships is key to designing effective TME-modulating agents.
- Further development of poly(amino acid)s holds significant potential for clinical oncology.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drugs that Stabilize Microtubules
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

